US Broker Ratings

Medtronic plc (MDT) Stock Analysis: Unveiling a 14.59% Potential Upside with Robust Dividend Yield

Medtronic plc (MDT), a cornerstone in the healthcare sector, is currently drawing significant investor attention with a market cap of $124.11 billion. Headquartered in Galway, Ireland, this medical device giant..

Grifols, S.A. (GRFS) Stock Analysis: Evaluating the 24.86% Upside Potential for Investors

Grifols, S.A. (NASDAQ: GRFS), a leading player in the healthcare sector, specializes in plasma therapeutics and offers a diverse range of products across the globe. As investors eye growth opportunities..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: Unpacking a 26% Upside Potential

Merit Medical Systems, Inc. (NASDAQ: MMSI), a stalwart in the healthcare sector, stands out for its impressive portfolio of single-use medical products tailored for interventional, diagnostic, and therapeutic procedures. As..

Jazz Pharmaceuticals plc (JAZZ) Stock Analysis: Strong Buy Ratings Signal a 27.76% Upside Potential

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a leading player in the biotechnology sector, stands out as a compelling investment opportunity with a robust pipeline and a considerable upside potential of 27.76%...

Molina Healthcare Inc (MOH) Stock Analysis: Is the Healthcare Plan Giant a Buy or Hold?

Molina Healthcare Inc (NYSE: MOH), a prominent player in the healthcare plans sector, has captured the attention of investors with its robust market presence and notable financial performance. Headquartered in..

HealthEquity, Inc. (HQY) Stock Analysis: Evaluating a 39.54% Potential Upside in the Healthcare Sector

HealthEquity, Inc. (NASDAQ: HQY) is a noteworthy player in the healthcare sector, specializing in health information services. With a market capitalization of $7.38 billion, HealthEquity offers a suite of technology-enabled..

Henry Schein, Inc. (HSIC) Stock Analysis: Navigating the Healthcare Distribution Giant with a -2.92% Potential Downside

Henry Schein, Inc. (NASDAQ: HSIC), a stalwart in the healthcare distribution sector, is a company that has consistently demonstrated its prowess in delivering medical and dental supplies across the globe...

ICON plc (ICLR) Stock Analysis: Unveiling a 12.64% Upside in the Healthcare Sector

ICON plc (NASDAQ: ICLR), a major player in the healthcare sector, has positioned itself as a pivotal entity in the diagnostics and research industry. Headquartered in Dublin, Ireland, ICON specializes..

Novo Nordisk A/S (NVO) Stock Analysis: Navigating the -10.31% Potential Downside with Strong Healthcare Innovations

Novo Nordisk A/S (NVO), a titan in the global healthcare sector, continues to dominate the drug manufacturing industry with its innovative approach to diabetes and obesity care, as well as..

Vertex Pharmaceuticals (VRTX) Investor Outlook: Analyzing Growth Potential Amid Robust Analyst Ratings

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) continues to captivate investor interest with its strong position in the biotechnology sector, primarily driven by its groundbreaking therapies for cystic fibrosis (CF) and promising..

Mettler-Toledo International, Inc. (MTD) Stock Analysis: Navigating Growth in Diagnostics & Research

Mettler-Toledo International, Inc. (NYSE: MTD) stands as a formidable player in the Healthcare sector, specifically within the Diagnostics & Research industry. With a market capitalization of $30.09 billion, the company..

The Cigna Group (CI) Investor Outlook: Unpacking the 20.10% Potential Upside

For those eyeing investments in the healthcare sector, The Cigna Group (NYSE: CI) presents an intriguing opportunity. This stalwart of the healthcare plans industry boasts a substantial market capitalization of..

West Pharmaceutical Services (WST) Stock Analysis: A 33% Potential Upside Amid Strong Buy Ratings

For individual investors eyeing opportunities in the healthcare sector, West Pharmaceutical Services, Inc. (NYSE: WST) presents an intriguing proposition. With a market capitalization of $18.69 billion, the company operates in..

Align Technology, Inc. (ALGN)

⚠️ No article content returned.

..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Evaluating a 10.99% Potential Upside in the Healthcare Sector

Bio-Rad Laboratories, Inc. (NYSE: BIO) stands as a significant player in the medical devices industry, part of the expansive healthcare sector. As a company with a rich history dating back..

Ascendis Pharma A/S (ASND) Stock Analysis: Strong Buy Ratings Signal Potential Upside of Nearly 28%

Ascendis Pharma A/S (NASDAQ: ASND), a Danish biopharmaceutical innovator in the biotechnology industry, is capturing investor attention with its promising growth trajectory and impressive analyst ratings. Operating globally, Ascendis focuses..

BioMarin Pharmaceutical Inc. (BMRN) Investor Outlook: Assessing a 64.95% Potential Upside

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) operates in the dynamic biotechnology sector, focusing on developing and commercializing therapies for rare diseases. Based in San Rafael, California, BioMarin has carved out a..

Koninklijke Philips N.V. (PHG) Stock Analysis: Navigating Potential Upside with a 9.94% Margin

Koninklijke Philips N.V. (PHG), a stalwart in the healthcare sector, continues to pique investor interest with its diverse offerings in the medical devices industry. Headquartered in Amsterdam, the Netherlands, Philips..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: A Strong Buy with 11.20% Potential Upside

Teva Pharmaceutical Industries (NYSE: TEVA), a global leader in generic and specialty medicines, is capturing investor attention with a notable potential upside of 11.20% based on its current average target..

AbbVie Inc. (ABBV) Investor Outlook: Analyzing a 14.32% Potential Upside Amid Robust Revenue Growth

AbbVie Inc. (NYSE: ABBV), a titan in the healthcare sector, continues to capture investor attention with its formidable presence in the biopharmaceutical landscape. With a market capitalization of $378.84 billion,..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds